Crossmark

Effectiveness and Safety of Colistimethate Sodium Used in the Treatment of Neutropenic Blood Cancer Patients Infected with Multidrug-Resistant Pseudomonas aeruginosa

Crossref DOI link: https://doi.org/10.1007/s13369-024-08830-z

Published Online: 2024-03-06

Published Print: 2024-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Salman, Alaa

Ghannam, Ameera

Kittaneh, Ala’a

Abu-zant, Aladdin

Sahoury, Yousef

Sahouri, Ekram

Abuamsha, Ruba

Salman, Mazen https://orcid.org/0000-0001-9886-6782
License Information

Text and Data Mining valid from 2024-03-06

Version of Record valid from 2024-03-06
More Information

Article History

Received: 13 December 2023

Accepted: 31 January 2024

First Online: 6 March 2024

Declarations

:

: All authors declare no conflict of interest.

Document is current

Any future updates will be listed below